General Assembly Raised Bill No. 539
February Session, 2018 LCO No. 3197
*_____SB00539FIN___040618____*
Referred to Committee on FINANCE, REVENUE AND BONDING
Introduced by:
(FIN)
General Assembly
Raised Bill No. 539
February Session, 2018
LCO No. 3197
*_____SB00539FIN___040618____*
Referred to Committee on FINANCE, REVENUE AND BONDING
Introduced by:
(FIN)
AN ACT CONCERNING A WORKING GROUP TO DEVELOP A PLAN TO FOSTER THE MICROBIOME SECTOR IN THE STATE.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Section 132 of public act 17-2 of the June special session is repealed and the following is substituted in lieu thereof (Effective from passage):
(a) There is established a working group to devise a roadmap to establish the state as a national leader in the development and commercialization of new microbiome-based treatments, products and services. In devising the roadmap, the working group shall examine all of the following, in addition to any other initiatives the working group deems appropriate and necessary to accomplish its duties under this section:
(1) Best practices of states and institutions recognized as leaders in the microbiome field, including, but not limited to, the University of California, San Diego Center for Microbiome Innovation, its associated initiatives and partners and its business networks and connections;
(2) The relative importance of and interrelationship between pure microbiome research and commercialization activity, and best practices to stimulate both;
(3) Whether it would be in the best interest of the state to develop a specialization or specializations within the human, animal or environmental microbiome field or any subfield thereof;
(4) (A) The talent pool and skills necessary to establish the state as a leader in the microbiome industry, (B) the educational curricula and training levels required to fill such needs and the level at which public and independent institutions of higher education in the state are meeting such requirements, (C) the ability of the state to attract out-of-state individuals with such talent and skills, and (D) a determination of how to develop such talent and skills to the levels required to meet the goals and requirements of this subsection, in terms of the skills required, the needed number of skilled workers in the state and specific academic and practical training recommended to be strengthened at such institutions; and
(5) The strength and amount of academic expertise in the microbiome field at public and independent institutions of higher education in the state, including how aligned such expertise is with the working group's roadmap, considering such institutions' plans to grow and deepen such expertise and technology commercialization efforts by faculty at such institutions.
(b) The working group shall consist of (1) the Commissioners of Economic and Community Development, Public Health and Revenue Services, or their designees, (2) the chairperson of the CTNext board of directors or the chairperson's designee, (3) the president of The University of Connecticut or the president's designee, (4) the dean of The University of Connecticut School of Medicine or the dean's designee, (5) the president of the Board of Regents for Higher Education or the president's designee, and (6) the following, to be appointed by the Governor: (A) One representative of an independent institution of higher education in the state; (B) one representative of an independent medical school in the state; (C) one representative from Yale University or Yale University School of Medicine; (D) two representatives of bioscience companies located in the state and in business for five years or more; (E) two representatives of bioscience companies located in the state and in business for less than five years; (F) one representative of a venture capital firm located in the state; and (G) one individual who represents hospitals in the state. The working group may consult with industry stakeholders and representatives of microbiome companies, representatives of educational and research institutions that are focused on the microbiome sector, representatives of the medical field who have expertise in the medical applications of microbiome-based products and services and any other individuals or representatives of fields the working group deems necessary or appropriate to inform it on the microbiomes sector.
(c) The Governor shall select the chairperson of the working group from among the members of the working group. Such chairperson shall schedule the first meeting of the working group, which shall be held not later than sixty days after the effective date of this section.
(d) The administrative staff of the joint standing committee of the General Assembly having cognizance of matters relating to finance, revenue and bonding shall serve as administrative staff of the task force.
(e) Notwithstanding the provisions of section 2-15 of the general statutes, no member of the working group shall receive mileage reimbursement or a transportation allowance for traveling to or from a meeting of the working group.
(f) Not later than January 1, [2018] 2019, the working group shall submit a report, in accordance with section 11-4a of the general statutes, of its roadmap developed pursuant to subsection (a) of this section to the joint standing committees of the General Assembly having cognizance of matters relating to finance, revenue and bonding, commerce and public health. The report shall include (1) recommendations for legislative and programmatic changes to effectuate the roadmap, (2) for each such recommended change, a proposed budget, listing options for full, medium and low funding levels, and (3) for each such recommended change, recommended measureable and achievable goals and a proposed timetable for accomplishing such change.
(g) Not later than February 1, [2018] 2019, the working group shall make a presentation of its report under subsection (e) of this section to the Governor and at a joint presentation to the joint standing committees of the General Assembly having cognizance of matters relating to finance, revenue and bonding, commerce and public health.
Sec. 2. Special act 17-16 is repealed. (Effective from passage)
This act shall take effect as follows and shall amend the following sections:
Section 1 from passage PA 17-2 of the June Sp. Sess., Sec. 132
Sec. 2 from passage Repealer section
This act shall take effect as follows and shall amend the following sections:
Section 1
from passage
PA 17-2 of the June Sp. Sess., Sec. 132
Sec. 2
from passage
Repealer section
FIN Joint Favorable
FIN
Joint Favorable